This session will delve into the data for Len Pem in advanced endometrial cancer (pMMR only) and feature case-based discussions on the management of patients receiving Lenvima and pembrolizumab. Key topics will include:

  • Managing long-term treatment with Lenvima and pembrolizumab, presented by Sam Gibson.
  • Addressing overlapping toxicities in this patient group, with insights from Nicole Haydon.
  • Overcoming challenges related to poor health literacy in patients with advanced endometrial cancer undergoing treatment, discussed by Anne Mellon. 

Join us for an engaging and informative session designed to provide practical strategies for managing complex cases of advanced endometrial cancer.

In collaboration with our national parter

Sam Gibson

Sam Gibson

Nicole  Kinnane

Nicole Kinnane

Anne Mellon

Anne Mellon

Find out more